Xencor | XNCR - Devedores Comerciais





Devedores Comerciais Alterar Data
AbbVie USD 12.59B 180M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amgen USD 9.57B 1.08B 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
AstraZeneca USD 17.88B 1.17B 2026-03
Biogen USD 1.87B 17M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Cytokinetics USD 1.81M 6.6M 2025-09
GlaxoSmithKline GBP 7.76B 545M 2025-12
J&J USD 21.33B 3.72B 2025-12
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
MacroGenics USD 13.37M 55.86M 2025-12
Merck USD 12.12B 596M 2025-09
Novartis USD 12.29B 3.3B 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Xencor USD 29.3M 7.49M 2025-12